Introduced
by
To require prescription drug manufacturers and wholesalers to adopt a comprehensive compliance program regarding ethical interactions with drug prescribers, including limits on gifts or incentives, a specific annual dollar limit on gifts, promotional materials, etc., and more. A firm would have to post details on its website. House Bill 6159 authorizes fines.
Referred to the Committee on Health Policy
